GSTP1 and breast carcinoma: Individuals with GSTP1 Val/Val genotype had significantly better survival in hepatocellular carcinoma patients (Cheng-Gang et al., 2012), but this genotype is associated with worse outcome in basal cell carcinoma (Ramachamdran et al., 2000) and breast cancer (Zhang et al., 2011).